Matches in Wikidata for { <http://www.wikidata.org/entity/Q90678094> ?p ?o ?g. }
Showing items 1 to 45 of
45
with 100 items per page.
- Q90678094 description "2019 թվականի հոկտեմբերի 10-ին հրատարակված գիտական հոդված" @default.
- Q90678094 description "artículu científicu espublizáu n'ochobre de 2019" @default.
- Q90678094 description "im Oktober 2019 veröffentlichter wissenschaftlicher Artikel" @default.
- Q90678094 description "scientific article published on 10 October 2019" @default.
- Q90678094 description "wetenschappelijk artikel" @default.
- Q90678094 description "наукова стаття, опублікована 10 жовтня 2019" @default.
- Q90678094 name "Cost-effectiveness of Osimertinib as a Second-line Treatment in Patients With EGFR-mutated Advanced Non-Small Cell Lung Cancer in China" @default.
- Q90678094 name "Cost-effectiveness of Osimertinib as a Second-line Treatment in Patients With EGFR-mutated Advanced Non-Small Cell Lung Cancer in China" @default.
- Q90678094 type Item @default.
- Q90678094 label "Cost-effectiveness of Osimertinib as a Second-line Treatment in Patients With EGFR-mutated Advanced Non-Small Cell Lung Cancer in China" @default.
- Q90678094 label "Cost-effectiveness of Osimertinib as a Second-line Treatment in Patients With EGFR-mutated Advanced Non-Small Cell Lung Cancer in China" @default.
- Q90678094 prefLabel "Cost-effectiveness of Osimertinib as a Second-line Treatment in Patients With EGFR-mutated Advanced Non-Small Cell Lung Cancer in China" @default.
- Q90678094 prefLabel "Cost-effectiveness of Osimertinib as a Second-line Treatment in Patients With EGFR-mutated Advanced Non-Small Cell Lung Cancer in China" @default.
- Q90678094 P1433 Q90678094-2CDD58E8-8F78-472A-A2A4-EEBDC65CC4CB @default.
- Q90678094 P1476 Q90678094-EC58A03B-1923-4DDA-A6B0-28ADA4A6A0E5 @default.
- Q90678094 P2093 Q90678094-083937E3-ACC6-4846-ABCA-B2E913BC82F4 @default.
- Q90678094 P2093 Q90678094-2E708AB8-D433-4DA1-94E8-C0CA176E6136 @default.
- Q90678094 P2093 Q90678094-6C7C6EB0-CF8A-46A3-AEA1-7B2B9A8038DE @default.
- Q90678094 P2093 Q90678094-8747E388-8EC3-456E-A13C-B17C518C555A @default.
- Q90678094 P2093 Q90678094-CB13395D-85F5-48E0-B255-6AA08B48D46E @default.
- Q90678094 P304 Q90678094-997C8461-2365-440C-8CD4-3985FDE2E177 @default.
- Q90678094 P31 Q90678094-00227682-6D97-4B37-BAC0-109C49BE6DB3 @default.
- Q90678094 P356 Q90678094-79B6FA70-EF67-41EE-AC91-7C22577E8900 @default.
- Q90678094 P433 Q90678094-7B70F901-98FD-4CB6-9970-938B9AC6DA44 @default.
- Q90678094 P478 Q90678094-4B8111F1-3501-4326-85C5-A3487663A7A4 @default.
- Q90678094 P577 Q90678094-750AFD92-DAEE-45AC-9D6D-47D0B20B4E4F @default.
- Q90678094 P698 Q90678094-875CB495-9748-4095-A7C8-89F1B0BE3EA9 @default.
- Q90678094 P921 Q90678094-B03B1769-2E5B-43E2-B98D-D4223E5BD96E @default.
- Q90678094 P356 J.CLINTHERA.2019.09.008 @default.
- Q90678094 P698 31607559 @default.
- Q90678094 P1433 Q15716601 @default.
- Q90678094 P1476 "Cost-effectiveness of Osimertinib as a Second-line Treatment in Patients With EGFR-mutated Advanced Non-Small Cell Lung Cancer in China" @default.
- Q90678094 P2093 "Feng Xie" @default.
- Q90678094 P2093 "Gordon Liu" @default.
- Q90678094 P2093 "Haijing Guan" @default.
- Q90678094 P2093 "Luwen Shi" @default.
- Q90678094 P2093 "Yanan Sheng" @default.
- Q90678094 P304 "2308-2320.e11" @default.
- Q90678094 P31 Q13442814 @default.
- Q90678094 P356 "10.1016/J.CLINTHERA.2019.09.008" @default.
- Q90678094 P433 "11" @default.
- Q90678094 P478 "41" @default.
- Q90678094 P577 "2019-10-10T00:00:00Z" @default.
- Q90678094 P698 "31607559" @default.
- Q90678094 P921 Q3658562 @default.